PD-1 and PD-L1 Inhibitors – Competitive Landscape, Pipeline and Market Analysis, 2017
"PD-1 and PD-L1 inhibitors – Competitive Landscape, Pipeline and Market Analysis, 2017" report provides the analysis on the worldwide therapeutic market of PD-1 and PD-L1 inhibitors including information of Marketed molecules, detailed profiling of Pipeline assets and their pathways. The report covers the therapeutics assessment of pipeline molecules by the mechanism of action (MoA), route of administration (RoA), molecule type, along with latest updates. The report deals with the detailed epidemiology of all prevalent indications.
View full press release